Update on Biomarkers of Hepatocellular Carcinoma

Slides:



Advertisements
Similar presentations
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma  Boris Guiu, Anne Minello, Vanessa Cottet, Côme.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis  Francesca Bravi, Cristina Bosetti, Alessandra Tavani, Silvano Gallus, Carlo.
Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Pulling the Trigger on Pancreatic Cysts
Ruben Hernaez, MD, MPH, PhD  Clinical Gastroenterology and Hepatology 
Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun.
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma  Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer,
Chemoembolization and Radioembolization for Hepatocellular Carcinoma
Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection  Adam.
Michael Camilleri, Anthony Lembo, David A. Katzka 
Coordinating Care in Patients With Cirrhosis
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Hepatocellular Carcinoma: Overcoming Challenges in Disease Management
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Aravind Sugumar, Suresh T. Chari 
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers  Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko.
Leigh Ann White, Joseph Menzin, Jonathan R
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis  Ashwani K. Singal, Amanpal Singh, Sathya.
Miles Basil, Anita Pudusseri, Robert Lowe 
Endoscopy 20 Years Into the Future
Jessica L. Mellinger, Michael L. Volk 
Amie L. Harvey, Tommy Yen, Anand Kunda 
Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma
Joanna Gibson, Jill Lacy, Ellen Matloff, Marie Robert 
Miho Sakumura, Kazuto Tajiri, Toshiro Sugiyama 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Josep M. Llovet  Clinical Gastroenterology and Hepatology 
Lance L. Stein, MD, Marty T. Sellers, MD, MPH 
George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B
An Asymptomatic, Radiographically Undetected Hepatocellular Carcinoma That Presented as a Large Retropancreatic Mass  Najat Mourra, Lionel Arrive, François.
Intragastric Fistula After Multiple Sphere Magnet Ingestion
Peter Richardson, Zhigang Duan, Jennifer Kramer, Jessica A
Isolated Metastasis of Hepatocellular Carcinoma in the Right Ventricle
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen  Myron John Tong, Michael Ong Nguyen, Lori Terese Tong, Lawrence.
An Unusual Presentation of Hematemesis: A Presentation of Maxillary Metastasis From Hepatocellular Carcinoma  Ming–Jong Bair, Wei–Yi Lei, Chien–Lin Chen 
Patient-Reported Outcomes of Cirrhosis
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A
Alan Bonder, MD, Nezam H. Afdhal, MD 
Michael L. Volk, MD, MSc, AGAF 
Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T
Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization  Madhu Subramanian, Amit G. Singal,
Thrombocytopenia With Abnormal Liver Function Tests
Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N
Hematochezia From Metastasis of Hepatocellular Carcinoma to Colon in a Patient Who Underwent Liver Transplantation  Ruhail Kohli, Andrei S. Purysko, Binu.
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Sun–Young Kim, Min–Geun Kim, Won–Choong Choi 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Issue Highlights Clinical Gastroenterology and Hepatology
Prognostic Significance of Simultaneous Measurement of Three Tumor Markers in Patients With Hepatocellular Carcinoma  Hidenori Toyoda, Takashi Kumada,
A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma  Boris Guiu, Anne Minello, Vanessa Cottet, Côme.
Medical Therapy for Refractory Pediatric Crohn’s Disease
Volume 156, Issue 4, Pages (March 2019)
Factors Associated With Outcomes and Response to Therapy in Patients With Infiltrative Hepatocellular Carcinoma  Neil Mehta, Nicholas Fidelman, Monika.
The Role of Psychosocial Care in Adapting to Health Care Reform
Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies  Robert D. Mair, Antonia Valenzuela, Nghiem B.
Presentation transcript:

Update on Biomarkers of Hepatocellular Carcinoma Roongruedee Chaiteerakij, Benyam D. Addissie, Lewis R. Roberts  Clinical Gastroenterology and Hepatology  Volume 13, Issue 2, Pages 237-245 (February 2015) DOI: 10.1016/j.cgh.2013.10.038 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Applications of established and novel HCC biomarkers in clinical care. Clinical Gastroenterology and Hepatology 2015 13, 237-245DOI: (10.1016/j.cgh.2013.10.038) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 Performance of AFP, AFP-L3%, and DCP for early HCC diagnosis in patients with cirrhosis. AUC, area under the curve. Clinical Gastroenterology and Hepatology 2015 13, 237-245DOI: (10.1016/j.cgh.2013.10.038) Copyright © 2015 AGA Institute Terms and Conditions

Figure 3 Arterial-phase computed tomography image of a large HCC tumor shown to have FGF3/FGF4 amplification before sorafenib treatment (A). After treatment with sorafenib for 2 months, the tumor size was substantially decreased as shown in the arterial phase (B) and hepatocyte phase (C) magnetic resonance images. (Panel A reproduced with permission from Arao T et al. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology 2013;57:1407-1415; Panels B and C courtesy of Dr Masatoshi Kudo, used with permission) Clinical Gastroenterology and Hepatology 2015 13, 237-245DOI: (10.1016/j.cgh.2013.10.038) Copyright © 2015 AGA Institute Terms and Conditions